Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Häufige urologisch-sexualmedizinische Themen in der Praxis sind das Thema des MMW-Webinars am 5. Juni von 17.30 bis 19 Uhr. Konkret geht es um die Frage, wann bei Harnwegsinfektionen auf Antibiotika verzichtet werden kann, und um ein Update zur Therapie von Libido- und Potenzstörungen des Mannes. Der dritte Vortrag behandelt sexuell übertragbare Krankheiten. Stellen Sie Ihre Fragen an die Experten und sammeln Sie 2 CME-Punkte. Jetzt gleich anmelden!
Erweiterte Suche
Anmelden
nach oben
Journal of Assisted Reproduction and Genetics
Erschienen in: Journal of Assisted Reproduction and Genetics 9/2016

18.06.2016 | Assisted Reproduction Technologies

Perinatal outcomes of singleton siblings: the effects of changing maternal fertility status

verfasst von: Barbara Luke, Daksha Gopal, Howard Cabral, Hafsatou Diop, Judy E. Stern

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The objective of this study was to evaluate the effect of changing fertility status on perinatal outcomes of singleton siblings, conceived with and without assisted reproductive technology (ART).

Method

A longitudinal cohort study of Massachusetts resident women having two consecutive singleton births during 2004–2010 was performed. Women were classified as ART (A), subfertile (S), or fertile (F) and categorized by their fertility status in each birth as A-A, A-S, S-A, S-S, F-A, F-S, and F-F. Within categories, adjusted mean birthweights, gestations, and birthweight Z scores were estimated with linear generalized estimating equations. Risks of low birthweight (LBW, <2500 g), preterm birth (PTB, <37 weeks), and placental complications were modeled using logistic regression by fertility status as adjusted odds ratios (AORs) and 95 % confidence intervals (CIs).

Results

Birthweights in second pregnancies averaged 74–155 g higher, except for births to F-A women, who averaged −16 g lower. Most women had a reduction in length of gestation in their second pregnancies, with F-A women having the largest decline (−0.5 weeks). In first birth models, the risks for LBW and placental complications were increased for subfertile (AOR 1.39 [1.07–1.81] and 1.97 [1.33–2.93], respectively) and ART women (AOR 1.58 [1.29–1.93] and 3.40 [2.64–4.37], respectively). Second birth models showed increased risks for ART births of LBW (AOR 3.13 [2.19–4.48]) and placental complications (AOR 2.45 [1.56–3.86]) and greater risks of PTB for both ART (AOR 2.37 [1.74–3.23]) and subfertile women (AOR 1.47 [1.02–2.13]).

Conclusions

Declining fertility status, with and without assisted reproductive technology treatment, is associated with increasing risks for adverse outcomes, greatest for women whose fertility status declined the most.
Literatur
1.
Schieve LA, Meikle SF, Ferre C, Peterson HB, Jeng G, Wilcox LS. Low and very low birthweight in infants conceived with use of assisted reproductive technology. N Engl J Med. 2002;346:731–7.CrossRefPubMed
2.
Helmerhorst FM, Perquin DAM, Donker D, Keirse MJNC. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. BMJ. 2004;328:261–5.CrossRefPubMedPubMedCentral
3.
Wang YA, Sullivan EA, Black D, Dean J, Bryant J, Chapman M. Preterm birth and low birth weight after assisted reproductive technology-related pregnancy in Australia between 1996 and 2000. Fertil Steril. 2005;83:1650–8.CrossRefPubMed
4.
Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol. 2004;103:551–63.CrossRefPubMed
5.
McDonald SD, Han Z, Mulla S, Murphy KE, Beyene J, Ohlsson A, et al. Preterm birth and low birth weight among in vitro fertilization singletons: a systematic review and meta-analyses. Eur J Obstet Gynecol Reprod Biol. 2009;146:138–48.CrossRefPubMed
6.
Buck Louis GM, Schisterman EF, Dukic VM, Schieve LA. Research hurdles complicating the analysis of infertility treatment and child health. Hum Reprod. 2005;20:12–8.CrossRefPubMed
7.
8.
Kondapalli LA, Perales-Puchalt A. Low birth weight: is it related to assisted reproductive technology or underlying infertility? Fertil Steril. 2013;99:303–10.CrossRefPubMedPubMedCentral
9.
Shimizu Y, Kodama H, Fukuda J, Murata M, Kumagai J, Tanaka T. Spontaneous conception after the birth of infants conceived through in vitro fertilization treatment. Fertil Steril. 1999;71:35–9.CrossRefPubMed
10.
Romundstad LB, Romundstad PR, Sunde A, von Düring V, Vatten LJ. Increased risk of placenta previa in pregnancies following IVF/ICSI; a comparison of ART and non-ART pregnancies in the same mother. Hum Reprod. 2006;21:2353–8.CrossRefPubMed
11.
Romundstad LB, Romundstad PR, Sunde A, von Düring V, Skjærven R, Gunnell D, et al. Effects of technology or maternal factors on perinatal outcome after assisted fertilization: a population-based cohort study. Lancet. 2008;372:737–43.CrossRefPubMed
12.
Shih W, Rushford DD, Bourne H, Garrett C, McBain JC, Healy DL, et al. Factors affecting low birthweight after assisted reproduction technology: difference between transfer of fresh and cryopreserved embryos suggests an adverse effect of oocyte collection. Hum Reprod. 2008;23:1644–53.CrossRefPubMed
13.
Henningsen A-KA, Pinborg A, Lidegaard Ø, Vestergaard C, Forman JL, Andersen AN. Perinatal outcome of singleton siblings born after assisted reproductive technology and spontaneous conception: Danish national sibling-cohort study. Fertil Steril. 2011;95:959–63.CrossRefPubMed
14.
Kotelchuck M, Hoang L, Stern JE, Diop D, Belanoff C, Declercq E. The MOSART database: linking the SART CORS clinical database to the population-based Massachusetts PELL reproductive public health data system. Matern Child Health J. 2014. doi:10.​1007/​s10995-014-1465-4.PubMedCentral
15.
Declercq ER, Belanoff C, Diop H, Gopal D, Hornstein MD, Kotelchuck M, et al. Identifying women with indicators of subfertility in a statewide population database: operationalizing the missing link in ART research. Fertil Steril. 2014;101:463–71.CrossRefPubMed
16.
Stern JE, Kotelchuck M, Luke B, Declercq E, Cabral H, Diop H. Calculating length of gestation from the Society for Assisted Reproductive Technology Clinic Outcome Reporting System (SART CORS) database versus vital records may alter reported rates of prematurity. Fertil Steril. 2014;101:1315–20.CrossRefPubMedPubMedCentral
17.
Stern JE, Luke B, Hornstein MD, Cabral H, Gopal D, Diop H, et al. The effect of father’s age in fertile, subfertile, and assisted reproductive technology pregnancies: a population based cohort study. J Assist Reprod Genet. 2014;31:1437–44.CrossRefPubMedPubMedCentral
18.
Getz KD, Liberman RF, Luke B, Stern JE, Declercq E, Anderka MT. The occurrence of birth defects in relation to assisted reproductive technologies in the Massachusetts Outcomes Study of Assisted Reproductive Technology database. Fertil Steril. 2014;102:e4.CrossRef
19.
Declercq E, Luke B, Belanoff C, Cabral H, Diop H, Gopal D, et al. Perinatal Outcomes Associated with Assisted Reproductive Technology: the Massachusetts Outcomes Study of Assisted Reproductive Technologies (MOSART). Fertil Steril. 2015;103:888–95.CrossRefPubMedPubMedCentral
20.
Stern JE, Luke B, Tobias M, Gopal D, Hornstein MD, Diop H. Adverse pregnancy and birth outcomes by infertility diagnoses with and without ART treatment. Fertil Steril. 2015;103:1438–45.CrossRefPubMedPubMedCentral
21.
Luke B, Stern JE, Kotelchuck M, Declercq ER, Hornstein MD, Gopal D, et al. Adverse pregnancy outcomes after in vitro fertilization: effect of number of embryos transferred and plurality at conception. Fertil Steril. 2015;104:79–86.CrossRefPubMedPubMedCentral
22.
Declercq ER, Luke B, Stern JE, Diop H, Gopal D, Cabral H, et al. Maternal postpartum hospitalization following ART births (research letter). Epidemiology. 2015;26:e64–5.CrossRefPubMed
23.
Luke B, Stern JE, Kotelchuck M, Declercq E, Cohen B, Diop H. Birth outcomes by infertility diagnosis: analyses of the Massachusetts Outcomes Study of Assisted Reproductive Technologies (MOSART). J Reprod Med. 2015;60:480–90.PubMedPubMedCentral
24.
Diop H, Gopal D, Cabral H, Belanoff C, Declercq ER, Kotelchuck M, et al. Assisted reproductive technology and early intervention enrollment. Pediatrics. 2016;137(3):e20152007.CrossRefPubMed
25.
Luke B, Stern JE, Kotelchuck M, Declercq E, Anderka M, Diop H. Birth outcomes by infertility treatment: analyses of the Massachusetts Outcomes Study of Assisted Reproductive Technologies (MOSART). J Reprod Med. 2016;61:114–27.PubMed
26.
Belanoff C, Declercq ER, Diop H, Gopal D, Kotelchuck M, Luke B, et al. Severe maternal morbidity and the use of assisted reproductive technology. Obstet Gynecol. 2016;127:527–34.CrossRefPubMed
27.
Stern JE, Gopal D, Anderka M, Liberman R, Kotelchuck M, Luke B. Validation of birth outcomes in the SART CORS: population-based analysis from the Massachusetts Outcome Study of Assisted Reproductive Technology (MOSART). Fertil Steril. 2016. doi:10.​1016/​j.​fertnstert.​2016.​04.​042.
28.
Center for Disease Control and Prevention, American Society for Reproductive Medicine, and Society for Assisted Reproductive Technology. 2012 Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports. Washington, DC: US Dept. of Health and Human Services; 2014.
29.
Oken E, Kleinman KP, Rich-Edwards J, Gillman MW. A nearly continuous measure of birth weight for gestational age using a United States national reference. BMC Pediatr. 2003;3:6–16.CrossRefPubMedPubMedCentral
30.
31.
Farhi A, Reichman B, Boyko V, Hourvitz A, Ron-El R, Lerner-Geva L. Maternal and neonatal health outcomes following assisted reproduction. Reprod BioMed Online. 2013;26:454–61.CrossRefPubMed
32.
Sazonova A, Källen K, Thurin-Kjellberg A, Wennerholm U-B, Bergh C. Factors affecting obstetric outcome of singletons born after IVF. Hum Reprod. 2011;26:2878–86.CrossRefPubMed
33.
Hayashi M, Nakai A, Satoh S, Matsuda Y. Adverse obstetric and perinatal outcomes of singleton pregnancies may be related to maternal factors associated with infertility rather than the type of assisted reproductive technology procedure used. Fertil Steril. 2012;98:922–8.CrossRefPubMed
34.
ACOG Committee on Gynecologic Practice and the Practice Committee of ASRM. Female age-related fertility decline. Fertil Steril. 2014;101:633–4.CrossRef
35.
Luke B, Brown MB, Stern JE, Missmer SA, Fujimoto VY, Leach R. Female obesity adversely affects assisted reproductive technology (ART) pregnancy and live birth rates. Hum Reprod. 2011;26:245–52.CrossRefPubMed
36.
Salha O, Sharma V, Dada T, Nugent D, Rutherford AJ, Tomlinson AJ, et al. The influence of donated gametes on the incidence of hypertensive disorders of pregnancy. Hum Reprod. 1999;14:2268–73.CrossRefPubMed
37.
Keegan DA, Krey LC, Chang HC, Noyes N. Increased risk of pregnancy-induced hypertension in young recipients of donated oocytes. Fertil Steril. 2007;87:776–81.CrossRefPubMed
38.
Younis JS, Laufer N. Oocyte donation is an independent risk factor for pregnancy complications: the implications for women of advanced age. J Women’s Health. 2015;24:127–30.CrossRef
39.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol. 2000;183:S1–22.CrossRef
40.
Opdahl S, Henningsen AA, Tiitinen A, Bergh C, Pinborg A, Romundstad PR, et al. Risk of hypertensive disorders in pregnancies following assisted reproductive technology: a cohort study from the CoNARTaS group. Hum Reprod. 2015;30:1724–31.CrossRefPubMed
41.
Broekmans FJ, Kwee J, Hendricks DJ, Mol BW, Lambalk CB. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006;12:685–718.CrossRefPubMed
42.
Center for Disease Control and Prevention, American Society for Reproductive Medicine, and Society for Assisted Reproductive Technology. 2013 Assisted Reproductive Technology Success Rates: National Summary and Fertility Clinic Reports. Washington, DC: US Department of Health and Human Services; 2015.
43.
Balasch J, Gratacós E. Delayed childbearing: effects on fertility and the outcome of pregnancy. Curr Opin Obstet Gynecol. 2012;24:187–93.CrossRefPubMed
44.
Werler E, Mendola P, Männistö T, O’Loughlin J, Laughon SK. Effect of maternal chronic disease on obstetric complications in twin pregnancies in a United States cohort. Fertil Steril. 2013;100:142–9.CrossRef
45.
Sattar N, Greer IA. Pregnancy complications and maternal cardiovascular risk: opportunities for intervention and screening? BMJ. 2002;325:157–60.CrossRefPubMedPubMedCentral
46.
Hamilton BE, Martin JA, Osterman MJK, Curtin SC, Mathews TJ. Births: final data for 2014. Nat Vital Stati Rep. 2015;64:12.
47.
EP, Chiang V, Pletcher MJ, et al. History of gestational diabetes mellitus and future risk of atherosclerosis in mid-life: the Coronary Artery Risk Development in Young Adults Study. J Am Heart Assoc. 2014;3. doi:10.​1161/​JAHA.​113.​000490
48.
Rich-Edwards JW, Fraser A, Lawlor DA, et al. Pregnancy characteristics and women’s future cardiovascular health: an underused opportunity to improve women’s health? Epidemiol Rev. 2014;SI:57–70.CrossRef
49.
Fraser A, Nelson SM, MacDonald-Wallis C, et al. Associations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age. The Avon Longitudinal Study of Parents and Children. Circulation. 2012;125:1367–80.CrossRefPubMedPubMedCentral
50.
Catov JM, Ness RB, Wellons MF, et al. Prepregnancy lipids related to preterm birth risk: the Coronary Artery Risk Development in Young Adults Study. J Clin Endocrinol Metab. 2010;95:3711–8.CrossRefPubMedPubMedCentral
51.
Mongraw-Chaffin ML, Cirillo PM, Cohn BA. Preeclampsia and cardiovascular disease death prospective evidence from the Child Health and Development Studies cohort. Hypertension. 2010;56:166–U264.CrossRefPubMedPubMedCentral
52.
Retnakaran R, Qi Y, Connelly PW, et al. Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J Clin Endocrinol Metab. 2010;95:670–7.CrossRefPubMed
53.
White WM, Mielke MM, Araoz PA, Lahr BD, Bailey KR, Jayachandran M, et al. A history of preeclampsia is associated with a risk for coronary artery calcification 3 decades later. Am J Obstet Gynecol. 2016;214:519.e1-8.PubMed
54.
Boulet SL, Schieve LA, Nannini A, Ferre C, Devine O, Cohen B, et al. Perinatal outcomes of twin births conceived using assisted reproduction technology: a population-based study. Hum Reprod. 2008;23:1941–8.CrossRefPubMed
55.
Zhang Z, Macaluso M, Cohen B, Schieve L, Nannini A, Chen M, et al. Accuracy of assisted reproductive technology information on the Massachusetts birth certificate, 1997-2000. Fertil Steril. 2010;94:1657–61.CrossRefPubMed
56.
Mneimneh AS, Boulet SL, Sunderam S, Zhang YJ, Jamieson DJ, Crawford S, et al. States Monitoring Assisted Reproductive Technology (SMART) Collaborative: data collection, linkage, dissemination, and use. J Women’s Health. 2013;22:571–7.CrossRef
Metadaten
Titel
Perinatal outcomes of singleton siblings: the effects of changing maternal fertility status
verfasst von
Barbara Luke
Daksha Gopal
Howard Cabral
Hafsatou Diop
Judy E. Stern
Publikationsdatum
18.06.2016
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 9/2016
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-016-0757-6

Weitere Artikel der Ausgabe 9/2016

Journal of Assisted Reproduction and Genetics 9/2016 Zur Ausgabe

Reproductive Physiology and Disease

Reduced sperm DNA longevity is associated with an increased incidence of still born; evidence from a multi-ovulating sequential artificial insemination animal model

Gamete Biology

Closed vitrification of human oocytes and blastocysts: outcomes from a series of clinical cases

Commentary

The importance of redundancy of functional ovarian reserve when investigating potential genetic effects on ovarian function

Letter to Editor

Semen as virus reservoir?

Reproductive Physiology and Disease

Association of semen cytokines with reactive oxygen species and histone transition abnormalities

Assisted Reproduction Technologies

The effect on pregnancy and multiples of transferring 1–3 embryos in women at least 40 years old

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen
Bildnachweise